Medicine
Sofosbuvir and Velpatasvir 400 mg/100 mg tablet
Sofosbuvir and Velpatasvir 400 mg/100 mg tablet is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store below 30 °C (86 ºF).
Key facts
- Active ingredient (INN)
- Sofosbuvir and Velpatasvir
- Brand
- Sold under the generic name
- Strength
- 400 mg/100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 2 blister pack
- Manufacturer
- Asegua Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store below 30 °C (86 ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AP55 Sofosbuvir and Velpatasvir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 November 2018
- Identifiers
- RxCUI 1799212DailyMed set ID d0c1a945-4440-4b5c-81aa-693ed3db597cNDC 72626-2701Application NDA208341
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack | 72626-2701-1 | Asegua Therapeutics | 14 November 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sofosbuvir and Velpatasvir 400 mg/100 mg tablet.
Other strengths and forms of Sofosbuvir and Velpatasvir
Clinical summary
Sofosbuvir and Velpatasvir is a fixed-dose combination of a hepatitis C virus NS5A inhibitor and a hepatitis C virus nucleotide analog NS5B polymerase inhibitor indicated for the treatment of adults, among other approved uses. MedsAcross supplies Sofosbuvir and Velpatasvir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sofosbuvir and VelpatasvirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sofosbuvir and Velpatasvir prescribing information (Asegua Therapeutics) · U.S. National Library of Medicine, DailyMed
- Epclusa: European public assessment report (EPAR) · European Medicines Agency
Need Sofosbuvir and Velpatasvir 400 mg/100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.